Surface Oncology Inc. (SURF) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Surface Oncology Inc.

NASDAQ: SURF · Real-Time Price · USD
1.07
-0.01 (-0.93%)
At close: Sep 07, 2023, 10:00 PM

Surface Oncology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Revenue
30M 2.69M
Cost of Revenue
n/a n/a
Gross Profit
30M 2.69M
Operating Income
-61.87M -76.01M
Interest Income
n/a n/a
Pretax Income
-63.59M -78.48M
Net Income
-65.3M -79.46M
Selling & General & Admin
24.87M 25.13M
Research & Development
67M 53.57M
Other Expenses
n/a 74K
Operating Expenses
91.87M 78.7M
Interest Expense
1.72M 2.47M
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
91.87M 78.7M
Income Tax Expense
1.72M 977K
Shares Outstanding (Basic)
55.76M 44.24M
Shares Outstanding (Diluted)
55.76M 44.24M
EPS (Basic)
-1.17 -1.8
EPS (Diluted)
-1.17 -1.8
EBITDA
-61.87M -76.01M
EBIT
n/a n/a
Depreciation & Amortization
1.37M 1.57M